scispace - formally typeset
Open AccessJournal ArticleDOI

Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial

TLDR
OIT successfully induced desensitisation in most children within the study population with peanut allergy of any severity, with a clinically meaningful increase in peanut threshold.
About
This article is published in The Lancet.The article was published on 2014-04-12 and is currently open access. It has received 359 citations till now. The article focuses on the topics: Peanut allergy & Randomized controlled trial.

read more

Citations
More filters
Journal ArticleDOI

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management.

TL;DR: This review provides general information to serve as a primer for those embarking on understanding food allergy and also details advances and updates in epidemiology, pathogenesis, diagnosis, and treatment that have occurred over the 4 years since the last comprehensive review.
Journal ArticleDOI

AR101 Oral Immunotherapy for Peanut Allergy

Brian P. Vickery, +71 more
TL;DR: Treatment with AR101 resulted in higher doses of peanut protein that could be ingested without dose‐limiting symptoms and in lower symptom severity during peanut exposure at the exit food challenge than placebo, in this phase 3 trial of oral immunotherapy in children and adolescents who were highly allergic to peanut.
Journal ArticleDOI

Administration of a probiotic with peanut oral immunotherapy: A randomized trial

TL;DR: PPOIT was effective in inducing possible sustained unresponsiveness and immune changes that suggest modulation of the peanut-specific immune response and the relative contributions of probiotics versus OIT.
Journal ArticleDOI

EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

TL;DR: Patients and their families should be provided with information about the use of FA‐AIT for IgE‐mediated food allergy to allow them to make an informed decision about the therapy.
References
More filters
Journal ArticleDOI

Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy

TL;DR: Althoughthere was a tendency for immediate sensitivity to allergen to return late after discontinuation, there was a sustained reduction in the late skin response and associated CD3+ T-cell infiltration and interleukin-4 messenger RNA expression.
Journal ArticleDOI

Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study.

TL;DR: For example, this paper found that the prevalence of self-reported peanut and tree-nut allergy increased from 0.4% in 1997 to 0.8% in 2002 by a factor of 1.04% (95% CI, 0.9-1.24%).
Journal ArticleDOI

Allergen injection immunotherapy for seasonal allergic rhinitis

TL;DR: This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use and no long-term consequences from adverse events.
Related Papers (5)